Page last updated: 2024-10-17

citric acid, anhydrous and Myeloproliferative Disorders

citric acid, anhydrous has been researched along with Myeloproliferative Disorders in 1 studies

Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rejtö, L1
Schlammadinger, A1
László, P1
Kiss, A1
Telek, B1
Boda, Z1

Other Studies

1 other study available for citric acid, anhydrous and Myeloproliferative Disorders

ArticleYear
Use of a platelet filter test in patients with thrombocytosis.
    Platelets, 2000, Volume: 11, Issue:1

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Anticoagulants; Bleeding Time; Chronic Diseas

2000